Live
UK · Media ·

RELX (REL) reaffirms full-year outlook, anticipating robust revenue and profit growth

RELX, the Anglo-Dutch information and analytics company, reaffirmed its full-year outlook, anticipating robust underlying revenue and adjusted operating profit growth, alongside strong adjusted earnings per share growth on a constant currency basis. The update, released in the last 18 hours, highlighted strong new sales across its Risk, Scientific, Technical & Medical (STM), and Legal divisions. Shares of RELX are trading at 2,711p on Monday, April 27, 2026, up 0.6% from yesterday's close of 2,696p.

The Legal division proved a particular bright spot, achieving double-digit growth within its Law Firms and Corporate Legal segments. This performance was partly attributed to the success of AI-driven products, including Lexis+ with Protégé. This emphasis on AI as a growth driver contrasts with earlier investor concerns regarding potential AI disruption, which saw the stock fall 3.1% on April 23.

Executive Incentives

In a separate development, RELX announced new conditional share awards for its Chief Executive Officer, Erik Engstrom, and Chief Financial Officer, Nick Luff. These awards fall under the RELX PLC Long Term Incentive Plan 2023. The company's reaffirmation of its outlook and the positive contribution of AI-driven offerings suggest a stable trajectory for the large UK-based firm.

What Does It Mean

How AI products turned RELX's legal division into a growth engine

RELX is an information and analytics business that sells specialised data, software and insights to professional services firms. Their customers are lawyers, scientists, doctors, risk managers and corporate compliance teams who need reliable, up-to-date information to make decisions. RELX makes money by licensing access to databases and tools, charging subscription fees, and selling software that sits inside their clients' workflows. The company operates across four main divisions: Risk, Scientific, Technical & Medical, Legal, and Exhibitions.

The real story here is that RELX's Legal division has cracked the code on embedding AI into products that lawyers actually want to use. Lexis+ with Protégé, their AI-driven legal research tool, delivered double-digit growth in both their Law Firms and Corporate Legal segments. This matters because it directly contradicts the anxiety that has haunted RELX investors for months; on 23 April, the stock fell 3.1 per cent on fears that AI would disrupt their core business model by making their traditional information products obsolete. Instead, RELX has shown that AI can be integrated into their existing customer relationships to drive higher revenue per user. The company's reaffirmation of its full-year outlook, alongside strong new sales across all divisions, reinforces that this is not a temporary blip but a sustainable shift in how they monetise their content.

RELX is trading at 2,711p, up 0.6 per cent from yesterday's close of 2,696p. The modest gain reflects measured confidence; the market is digesting a strategic win rather than pricing in a dramatic rerating.

Think of it like a newspaper that spent years worried its readers would abandon print for free online content. Instead, the newspaper built a premium subscription app that uses AI to personalise stories and surface what matters most to each subscriber. Suddenly the threat becomes the product, and the old customer base becomes more valuable, not less.

RELX

REL·London Stock Exchange·UK
Industry
Publishing
CEO
Erik Engstrom
Employees
34,580
Headquarters
London, GB
Listed
1988
About

RELX PLC (REL) operates as a global information and analytics provider, serving professional and business clients across North America, Europe, and other international markets. The company's operations are structured into four key segments. Its Risk division delivers information-based analytics and decision-making tools, integrating public and industry-specific content with advanced technology and algorithms to aid in evaluating and predicting risk. The Scientific, Technical & Medical segment offers essential information and analytical resources, supporting institutions and professionals in scientific advancement and healthcare progress. Furthermore, the Legal segment provides legal, regulatory, and business information and analytics, enhancing client decision-making and productivity. Lastly, the Exhibitions segment organises events, combining in-person interactions with data and digital tools to help customers understand markets, source products, and finalise transactions. Established in 1903, the company is headquartered in London, United Kingdom.